The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
All trans retinoic acid in acute promyelocytic leukemia
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bennett, J. M., Catovsky, D., Daniel, M., Flandrin, G., Galton, D. A. G., Gralnick, H. R., & Sultan, C. (1976) · British Journal of Haematology · doi:10.1111/j.1365-2141.1976.tb03563.x · Cited by 5,602
Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia
Huang, M., Ye, Y., Chen, Sr., Chai, Jr., Lu, J., Zhoa, L., Gu, L., & Wang, Z. (1988) · Blood · doi:10.1182/blood.v72.2.567.567 · Cited by 2,445
Self-citationDifferentiation Therapy of Acute Promyelocytic Leukemia with Tretinoin (All-trans-Retinoic Acid)
Warrell, R. P., Frankel, S. R., Miller, W. H., Scheinberg, D. A., Itri, L. M., Hittelman, W. N., Vyas, R., Andreeff, M., Tafuri, A., Jakubowski, A., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199105163242002 · Cited by 1,251
Castaigne, S., Chomienne, C., Daniel, M., Ballerini, P., Berger, R., Fenaux, P., & Degos, L. (1990) · Blood · doi:10.1182/blood.v76.9.1704.1704 · Cited by 1,184
Self-citationAll-trans-Retinoic Acid in Acute Promyelocytic Leukemia
Tallman, M. S., Andersen, J. W., Schiffer, C. A., Appelbaum, F. R., Feusner, J. H., Ogden, A., Shepherd, L., Willman, C., Bloomfield, C. D., Rowe, J. M., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710093371501 · Cited by 1,073
Fenaux, P., Chastang, C., Chevret, S., Sanz, M., Dombret, H., Archimbaud, E., Fey, M., Rayon, C., Huguet, F., Sotto, J.-J., et al. (1999) · Blood · doi:10.1182/blood.v94.4.1192 · Cited by 754
Self-citationThe "Retinoic Acid Syndrome" in Acute Promyelocytic Leukemia
Frankel, S. R., Eardley, A., Lauwers, G., Weiss, M., & Warrell, R. P. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-4-292 · Cited by 705
Chen, Z., Brand, N. J., Chen, A., Chen, S. J., Tong, J. H., Wang, Z. Y., Waxman, S., & Zelent, A. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05757.x · Cited by 640
Self-citation15/17 TRANSLOCATION, A CONSISTENT CHROMOSOMAL CHANGE IN ACUTE PROMYELOCYTIC LEUKAEMIA
Rowley, J., Golomb, H., & Dougherty, C. (1977) · The Lancet · doi:10.1016/s0140-6736(77)91415-5 · Cited by 633
Breitman, T., Collins, S., & Keene, B. (1981) · Blood · doi:10.1182/blood.v57.6.1000.1000 · Cited by 571
Fenaux, P., Le Deley, M., Castaigne, S., Archimbaud, E., Chomienne, C., Link, H., Guerci, A., Duarte, M., Daniel, M., & Bowen, D. (1993) · Blood · doi:10.1182/blood.v82.11.3241.3241 · Cited by 516
Redner, R., Rush, E., Faas, S., Rudert, W., & Corey, S. (1996) · Blood · doi:10.1182/blood.v87.3.882.bloodjournal873882 · Cited by 442
Evidence for a 15; 17 translocation in every patient with acute promyelocytic leukemia
Larson, R. A., Kondo, K., Vardiman, J. W., Butler, A. E., Golomb, H. M., & Rowley, J. D. (1984) · The American Journal of Medicine · doi:10.1016/0002-9343(84)90994-x · Cited by 417
Muindi, J., Frankel, Sr., Miller, W. J., Jakubowski, A., Scheinberg, D., Young, C., Dmitrovsky, E., & Warrell, R. J. (1992) · Blood · doi:10.1182/blood.v79.2.299.bloodjournal792299 · Cited by 408
Annexin II and Bleeding in Acute Promyelocytic Leukemia
Menell, J. S., Cesarman, G. M., Jacovina, A. T., McLaughlin, M. A., Lev, E. A., & Hajjar, K. A. (1999) · New England Journal of Medicine · doi:10.1056/nejm199904013401303 · Cited by 387
Chomienne, C., Ballerini, P., Balitrand, N., Daniel, M., Fenaux, P., Castaigne, S., & Degos, L. (1990) · Blood · doi:10.1182/blood.v76.9.1710.1710 · Cited by 375
Self-citationAcute Promyelocytic Leukemia: Results of Treatment by Daunorubicin
Bernard, J., Weil, M., Boiron, M., Jacquillat, C., Flandrin, G., & Gemon, M.-F. (1973) · Blood · doi:10.1182/blood.v41.4.489.489 · Cited by 338
HILLESTAD, L. K. (1957) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1957.tb00124.x · Cited by 322
Muindi, J., Frankel, Sr., Miller, W. J., Jakubowski, A., Scheinberg, D., Young, C., Dmitrovsky, E., & Warrell, R. J. (1992) · Blood · doi:10.1182/blood.v79.2.299.299 · Cited by 314
Vahdat, L., Maslak, P., Miller, W. J., Eardley, A., Heller, G., Scheinberg, D., & Warrell, R. J. (1994) · Blood · doi:10.1182/blood.v84.11.3843.bloodjournal84113843 · Cited by 296
Wells, R. A., Catzavelos, C., & Kamel-Reid, S. (1997) · Nature Genetics · doi:10.1038/ng0997-109 · Cited by 270
Arnould, C., Philippe, C., Bourdon, V., Gregoire, M. J., Berger, R., & Jonveaux, P. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.9.1741 · Cited by 260
Kanamaru, A., Takemoto, Y., Tanimoto, M., Murakami, H., Asou, N., Kobayashi, T., Kuriyama, K., Ohmoto, E., Sakamaki, H., & Tsubaki, K. (1995) · Blood · doi:10.1182/blood.v85.5.1202.bloodjournal8551202 · Cited by 234
Fenaux, P., Castaigne, S., Dombret, H., Archimbaud, E., Duarte, M., Morel, P., Lamy, T., Tilly, H., Guerci, A., & Maloisel, F. (1992) · Blood · doi:10.1182/blood.v80.9.2176.2176 · Cited by 232
Therapy of Molecular Relapse in Acute Promyelocytic Leukemia
Coco, F. L., Diverio, D., Avvisati, G., Petti, M. C., Meloni, G., Pogliani, E. M., Biondi, A., Rossi, G., Carlo-Stella, C., Selleri, C., et al. (1999) · Blood · doi:10.1182/blood.v94.7.2225.419k03_2225_2229 · Cited by 229
Guglielmi, C., Paola Martelli, M., Diverio, D., Fenu, S., Luce Vegna, M., CantÙ‐Rajnoldi, A., Biondi, A., Grazia Cocito, M., Del Vecchio, L., Tabilio, A., et al. (1998) · British Journal of Haematology · doi:10.1046/j.1365-2141.1998.00871.x · Cited by 198
Huang, W., Sun, G., Li, X., Cao, Q., Lu, Y., Jang, G., Zhang, F., Chai, Jr., Wang, Z., & Waxman, S. (1993) · Blood · doi:10.1182/blood.v82.4.1264.1264 · Cited by 189
Self-citationBiondi, A., Rambaldi, A., Pandolfi, P., Rossi, V, Giudici, G., Alcalay, M., Lo Coco, F., Diverio, D., Pogliani, E., & Lanzi, E. (1992) · Blood · doi:10.1182/blood.v80.2.492.492 · Cited by 184
Douer, D., Preston-Martin, S., Chang, E., Nichols, P., Watkins, K., & Levine, A. (1996) · Blood · doi:10.1182/blood.v87.1.308.308 · Cited by 179
Ferrara, F., Morabito, F., Martino, B., Specchia, G., Liso, V., Nobile, F., Boccuni, P., Di Noto, R., Pane, F., Annunziata, M., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.6.1295 · Cited by 171
Long-term follow-up confirms the benefit of all-trans retinoic acid in acute promyelocytic leukemia
Fenaux, P., Chevret, S., Guerci, A., Fegueux, N., Dombret, H., Thomas, X., Sanz, M., Link, H., Maloisel, F., Gardin, C., et al. (2000) · Leukemia · doi:10.1038/sj.leu.2401859 · Cited by 170
Self-citationCD56 Expression in Acute Promyelocytic Leukemia: A Possible Indicator of Poor Treatment Outcome?
Murray, C. K., Estey, E. H., Paietta, E. M., Howard, R. S., Edenfield, W. J., Pierce, S., Mann, K. P., Bolan, C. D., & Byrd, J. C. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.1.293 · Cited by 132
Slack, J. L., Arthur, D., Lawrence, D. D., Mrózek, K., Mayer, R. J., Davey, F. R., Tantravahi, R. V., Pettenati, M. J., Bigner, S. H., Carroll, A. J., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.5.1786 · Cited by 114
Castaigné, S., Balitrand, N., de Thé, H., Dejean, A., Degos, L., & Chomienne, C. (1992) · Blood · doi:10.1182/blood.v79.12.3110.3110 · Cited by 101
Self-citationA Variant Form of Hypergranular Promyelocytic Leukemia (M3)
Bennett, J. M., Catovsky, D., Daniel, M., Flandrin, G., GALTON, D. A. G., GRALNICK, H. R., SULTAN, C., & GRALNICK, H. R. (1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-92-2-261 · Cited by 97
Partial Deletion of Long Arm of Chromosome 17
Golomb, H. M. (1976) · Archives of Internal Medicine · doi:10.1001/archinte.136.7.825 · Cited by 91
Jansen, J. H., Ridder, M. C. B.-D., Geertsma-Kleinekoort, W. M. C., Erpelinck-Verschueren, C. A. J., van Lom, K., Smit, E. M. E., Slater, R. M., Reijden, B. A. V., de Greef, G. E., Sonneveld, P., et al. (1999) · Blood · doi:10.1182/blood.v94.1.39.413a26_39_45 · Cited by 83
Epidemiology of acute promyelocytic leukemia in Italy
Avvisati, G., Mele, A., Stazi, M. A., Vegna, M. L., Pasquini, P., Mandelli, F., Rotoli, B., Rosa, G. D., Papa, G. F. S., Venditti, A., et al. (1991) · Annals of Oncology · doi:10.1093/oxfordjournals.annonc.a057974 · Cited by 21
Cited by
International Union of Pharmacology. LX. Retinoic Acid Receptors
Germain, P., Chambon, P., Eichele, G., Evans, R. M., Lazar, M. A., Leid, M., De Lera, A. R., Lotan, R., Mangelsdorf, D. J., & Gronemeyer, H. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.4.4 · Cited by 397
Vahdat, L., Maslak, P., Miller, W. J., Eardley, A., Heller, G., Scheinberg, D., & Warrell, R. J. (1994) · Blood · doi:10.1182/blood.v84.11.3843.bloodjournal84113843 · Cited by 296
α-Ketoglutarate attenuates Wnt signaling and drives differentiation in colorectal cancer
Tran, T. Q., Hanse, E. A., Habowski, A. N., Li, H., Ishak Gabra, M. B., Yang, Y., Lowman, X. H., Ooi, A. M., Liao, S. Y., Edwards, R. A., et al. (2020) · Nature Cancer · doi:10.1038/s43018-020-0035-5 · Cited by 161
Nuovo, G. J., Hagood, J. S., Magro, C. M., Chin, N., Kapil, R., Davis, L., Marsh, C. B., & Folcik, V. A. (2012) · Modern Pathology · doi:10.1038/modpathol.2011.166 · Cited by 123
“Transformed hematopoietic stem cells express receptors for vitamin A metabolites (55).”
BackgroundNuclear receptor superfamily: Principles of signaling
Germain, P., Altucci, L., Bourguet, W., Rochette-Egly, C., & Gronemeyer, H. (2003) · Pure and Applied Chemistry · doi:10.1351/pac200375111619 · Cited by 53
“Considering in addition the success story of retinoids in the therapy of acute promyelocytic leukemia [243,244] and the promise of cancer therapy and prevention by NR-derived drugs [245–247], it becomes clear that the NR family is of outstanding importance for both diagnosis and drug design.”
Background
Metadata
- Authors
- Degos, L., & Wang, Z. Y.
- Venue
- Oncogene
- Published
- 2001-10-29
- Volume
- 20
- Issue
- 49
- Pages
- 7140-7145
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W1987136467
- Cited by
- 272
- References
- 38
- FWCI
- 4.56
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.